A robust earnings structure that generates profits continuously and consistently
First written in FY2016. 13 of 38 entries say "Worsened", first in FY2021. Latest entry: FY2027-H1.
Nippon Shikizai moved to the "Worse" side of this theme in 2025, 5 years after the typical company in this theme (2020).
The whole theme swung hardest in 2020: 10 of 45 companies on the "Worse" side.
4 other companies' latest entry also says "Worsened".
- FY2027-H1WorsenedAnnual report
「Operating profit fell 54.4% year on year to ¥50 million, resulting in an ordinary loss of ¥14 million (ordinary profit of ¥90 million in the same period of the previous year) and an interim net loss attributable to owners of the parent of ¥21 million (interim net profit attributable to owners of the parent of ¥49 million in the same period of the previous year).」
While aiming to establish a stable earnings structure, the Company saw operating profit decline, and ordinary and net profit were in the red. - 2026-10-13Worseneds.kabutan.jp
「直近3ヵ月の実績である6-8月期(2Q)の連結経常損益は9200万円の赤字(前年同期は1500万円の黒字)に転落し、売上営業損益率は前年同期の0.6％→-1.2％に悪化した。」
6-8月期は連結経常損益が赤字に転落し、売上営業損益率もマイナスへ悪化した。 - 2026-10-13WorsenedEarnings
「In particular, labor costs have risen, including base-pay increases, to secure personnel in Japan, while subcontracted processing costs have remained high to make up for labor shortages. Raw material costs and various expenses have also risen due to inflation. We are therefore continuing efforts to reduce costs and continuing to ask customers to accept price increases reflecting inflation, as we work to maintain profitability.」
収益性の維持に取り組む方針を示す一方、コスト上昇と価格転嫁の遅れが収益性を圧迫している。 - FY2026WorsenedAnnual report
「The operating margin was 1.1%, down 1.7 percentage points from the previous consolidated fiscal year, as utilization declined in Japan amid the easing of fluctuations in orders, various costs rose due to inflation, and performance at the French consolidated subsidiary remained weak. The equity ratio improved by 1.6 percentage points to 24.2%, partly because the company remained profitable, as in the previous consolidated fiscal year.」
While aiming to strengthen earnings power and its financial position, the equity ratio improved, whereas the operating margin declined from 2.8% to 1.1%. - FY2026-H1WorsenedAnnual report
「As production facility utilization declined from the first half of the previous consolidated fiscal year, when domestic orders fluctuated, while inflation drove up raw material, labor and other expenses, and performance at the French consolidated subsidiary remained weak due in part to sluggish orders for pharmaceuticals and cosmetics, operating profit fell 77.4% year on year to ¥110 million, ordinary profit fell 78.7% to ¥90 million, and interim net income attributable to owners of the parent fell 80.6% to ¥49 million.」
While aiming to maintain and improve profitability, profit levels declined significantly due to lower facility utilization, higher costs and sluggish European orders. - FY2025-H1AdvancedAnnual report
「As a result of higher utilization of production facilities driven by a substantial increase in orders and efforts to reduce various costs, operating profit rose 70.9% year on year to ¥489 million, ordinary profit rose 56.0% to ¥424 million, and interim net income attributable to owners of the parent rose 16.4% to ¥252 million.」
Despite persistent inflation and expansion-related expenses, profit levels improved as higher orders lifted facility utilization and costs were reduced, marking progress toward the goal of establishing a stable earnings structure. - FY2025-Q1AdvancedAnnual report
「Improved production equipment utilization resulting from higher orders and efforts to reduce various costs resulted in operating income of ¥276 million, up 62.2% year on year; ordinary income of ¥262 million, up 64.3%; and net income attributable to owners of the parent of ¥146 million, up 4.8%.」
Despite higher expenses and inflation-driven cost increases, improved equipment utilization and cost reductions improved earnings, indicating progress toward the goal of a stable earnings structure. - FY2024-Q3RaisedAnnual report
「Under these operating conditions, we will steadily implement the measures of the “Mid-Term Business Strategy Vision (2022-2026)” to sustain profitability, promptly recover to performance levels before the spread of COVID-19 and achieve further growth beyond those levels.」
The wording has expanded the scope of the objectives from maintaining profitability and recovering to pre-pandemic performance levels to achieving further growth beyond those levels. - FY2024-Q2AdvancedAnnual report
「The substantial increase in revenue and efforts to reduce various costs resulted in operating income of ¥286 million, up 718.3% year on year; ordinary income of ¥272 million, up 934.9%; and net income attributable to owners of the parent of ¥217 million, up 189.3%.」
The substantial increase in revenue and efforts to reduce costs significantly improved operating, ordinary and net income in the six months ended the second quarter from the same period of the previous year, indicating progress toward the goal of a stable earnings structure. - FY2024-Q1AdvancedAnnual report
「In terms of earnings, although the Company continued to be affected by higher expenses associated mainly with the Phase III expansion of the Tsukuba Plant and rising prices for raw materials, utilities and various other expenses, the increase in revenue and efforts to reduce various costs resulted in operating income of ¥170 million, compared with an operating loss of ¥83 million in the same period of the previous year; ordinary income of ¥159 million, compared with an ordinary loss of ¥82 million; and net income attributable to owners of the parent of ¥139 million, compared with a net loss attributable to owners of the parent of ¥27 million.」
Despite the continuing effects of higher expenses and rising prices, revenue growth and cost reductions turned operating, ordinary and net losses in the same period of the previous year into profits, indicating progress toward the goal of a stable earnings structure. - FY2023AdvancedAnnual report
「The operating margin for the fiscal year under review improved 4.5 percentage points from the previous fiscal year to 1.4%, as revenue increased with the easing of the impact of COVID-19 and the Company made efforts to reduce various costs. The equity ratio declined 0.5 percentage points from the previous fiscal year to 18.8%, partly due to an increase in operating working capital accompanying the recovery in revenue.」
Although efforts to reduce various costs and the recovery in revenue improved the operating margin from negative territory to 1.4%, the equity ratio declined to 18.8%. - FY2023-Q3AdvancedAnnual report
「In terms of earnings, although expenses continued to rise due mainly to the Phase III expansion of the Tsukuba Plant, the increase in revenue and efforts to reduce various costs resulted in operating income of ¥82 million, compared with an operating loss of ¥267 million in the same period of the previous year; ordinary income of ¥71 million, compared with an ordinary loss of ¥194 million; and net income attributable to owners of the parent of ¥96 million, helped by a ¥40 million gain on the sale of investment securities, compared with a net loss attributable to owners of the parent of ¥126 million.」
Revenue growth and efforts to reduce costs brought operating, ordinary and net income into positive territory for the nine months ended the third quarter, with continued progress toward the goal of a continuous and stable earnings structure. - FY2023-Q2AdvancedAnnual report
「The increase in revenue and efforts to reduce various costs resulted in operating income of ¥35 million, compared with an operating loss of ¥190 million in the same period of the previous year; ordinary income of ¥26 million, compared with an ordinary loss of ¥121 million; and net income attributable to owners of the parent of ¥75 million, helped by a ¥40 million gain on the sale of investment securities, compared with a net loss attributable to owners of the parent of ¥116 million.」
Revenue growth and cost reductions brought operating income, ordinary income and net income into positive territory for the first-half cumulative period, representing measurable progress toward the goal of a stable earnings structure. - FY2023-Q1Revenue growth and cost reductions narrowed losses, but the Company remained loss-makingAnnual report
「The increase in revenue and efforts to reduce various costs resulted in an operating loss of ¥83 million, compared with an operating loss of ¥218 million in the same period of the previous year; an ordinary loss of ¥82 million, compared with an ordinary loss of ¥168 million; and a net loss attributable to owners of the parent of ¥27 million, helped by a ¥40 million gain on the sale of investment securities, compared with a net loss attributable to owners of the parent of ¥156 million.」
Although revenue growth and cost reductions substantially narrowed losses, operating, ordinary and net losses remained, and the Company had not yet achieved a stable profitable earnings structure. - FY2022Losses narrowed, but shortfalls against profitability and financial-strength targets continuedAnnual report
「The operating margin for the fiscal year under review was negative as revenue remained sluggish due to the prolonged impact of COVID-19, but improved 6.0 percentage points from the previous fiscal year to negative 3.1% as a result of efforts to reduce various costs. The equity ratio was 0.7 percentage points below that of the previous fiscal year, at 19.2%.」
Cost reductions improved the operating margin from negative 9.1% to negative 3.1%, but the operating deficit and decline in the equity ratio continued. - FY2022-Q3Loss narrows, but losses continueAnnual report
「In terms of earnings, in addition to the decline in revenue and higher expenses associated with completion of the “Phase III expansion work at the Tsukuba Plant,” a COVID-19 cluster at the Zama Plant in September 2021 forced a decline in plant operations, resulting in an operating loss of ¥267 million, compared with an operating loss of ¥414 million in the same period of the previous year.」
While targeting an earnings structure that generates profit consistently, the Company remained loss-making despite a narrower operating loss than in the same period of the previous year, due in part to expansion-related costs and lower plant utilization. - FY2022-Q2WorsenedAnnual report
「In terms of earnings, revenue declined while expenses increased in connection with completion of the “Phase III expansion work at the Tsukuba Plant,” resulting in an operating loss of ¥190 million, compared with an operating loss of ¥181 million in the same period of the previous year.」
While targeting an earnings structure that generates profit consistently, the operating loss in the first-half cumulative period widened from the same period of the previous year. - FY2022-Q1WorsenedAnnual report
「Equity ratio (%) 23.0 18.9 19.9」
While targeting stronger earnings power and financial strength, the equity ratio at the end of the first quarter was 18.9%, down from 19.9% at the end of the previous fiscal year. - FY2021WorsenedAnnual report
「The operating margin for the fiscal year under review was 12.8 percentage points below that of the previous fiscal year, at negative 9.1%, as the Company recorded an operating loss due to the impact of COVID-19. The equity ratio was also 5.4 percentage points below that of the previous fiscal year, at 19.9%.」
While targeting stronger earnings power and financial strength, the operating margin fell to negative 9.1% and the equity ratio to 19.9%. - FY2021-Q3Losses widened due to the impact of the pandemic and expansion costsAnnual report
「In terms of earnings, the sharp decline in revenue and higher expenses following completion of the “Phase III expansion work at the Tsukuba Plant” resulted in an operating loss of ¥414 million. The recording of ¥112 million in subsidy income and other items reduced the ordinary loss to ¥350 million, while the net loss attributable to owners of the parent was ¥248 million.」
While targeting an earnings structure that generates profit consistently, operating, ordinary and net losses continued in the nine months ended the third quarter due to the sharp decline in revenue and higher expenses following completion of the Phase III expansion work. - FY2021-Q2Cumulative first-half loss due to the pandemic and expansion costsAnnual report
「In terms of earnings, in addition to the sharp decline in revenue, expenses increased following completion of the “Phase III expansion work at the Tsukuba Plant,” resulting in an operating loss of ¥181 million, an ordinary loss of ¥189 million and a net loss attributable to owners of the parent of ¥135 million.」
While targeting an earnings structure that generates profit consistently, losses continued in the first-half cumulative period due to the sharp decline in revenue and higher expenses following completion of the expansion work. - FY2021-Q1The Company became loss-making due to the pandemic and expansion costsAnnual report
「In terms of earnings, in addition to the sharp decline in revenue, expenses increased following the completion of the “Phase III expansion work at the Tsukuba Plant,” resulting in an operating loss of ¥96 million, an ordinary loss of ¥116 million and a net loss attributable to owners of the parent of ¥84 million.」
While targeting an earnings structure that generates profit continuously and consistently, the Company posted losses due to the sharp decline in revenue and higher expenses following completion of the expansion work. - FY2020Management indicators deterioratedAnnual report
「The operating margin for the fiscal year under review decreased 4.4 percentage points from the previous fiscal year to 3.7%. The equity ratio also decreased 6.1 percentage points from the previous fiscal year to 25.3%.」
While targeting stronger earnings power and financial strength, both the operating margin and equity ratio declined from the previous fiscal year. - FY2020-Q3RestatedAnnual report
「There were no material changes during the nine-month consolidated period to the management policies, management strategies or other matters established by our group.」
There have been no material changes to management policies, management strategies or other matters, and the Company has maintained its previous direction of improving earnings power and building a stable earnings structure. - FY2020-Q2RestatedAnnual report
「Against this market backdrop, our Group has pursued the expansion of production capacity through initiatives including the ongoing “Phase III expansion work at the Tsukuba Plant,” as well as the acceleration of globalization through the creation of group synergies, under the “Mid-Term Business Strategy Vision (2017-2021),” launched in fiscal 2017.」
Under the Mid-Term Business Strategy Vision, the Company continues to pursue greater production capacity and accelerated globalization through group synergies as management objectives. - FY2019-Q3RestatedAnnual report
「Against this market backdrop, our Group (comprising the Company and its consolidated subsidiaries; the same applies below) is pursuing the creation of group synergies under the “Mid-Term Business Strategy Vision (2017-2021),” launched in fiscal 2017, to expand production capacity in Japan and accelerate globalization.」
The Company has reaffirmed its policy of expanding domestic production capacity and accelerating globalization through the creation of group synergies. - FY2018RestatedAnnual report
「Our Group regards improving earnings power and strengthening its financial position as its most important management objectives. Based on competitive R&D and technological capabilities, we aim to operate efficiently and profitably while raising the operating margin and equity ratio.」
The Company has reaffirmed its previous goal of building a stable earnings structure, using improved earnings power and financial strength, along with higher operating margins and equity ratios, as its metrics. - FY2018-Q2RestatedAnnual report
「Against this market backdrop, our Group (comprising the Company and its consolidated subsidiaries; the same applies below) pursued initiatives to create group synergies under the “Mid-Term Business Strategy Vision” launched this fiscal year, with the aim of further expanding production capacity in Japan and accelerating globalization.」
The Company has reaffirmed its policy of achieving greater production capacity and accelerating globalization through the creation of group synergies under the Mid-Term Business Strategy Vision. - FY2018-Q1RestatedAnnual report
「Against this market backdrop, our Group (comprising the Company and its consolidated subsidiaries; the same applies below) continued to promote proposal-based sales supported by innovative formulation development, based on the “Mid-Term Business Strategy Vision” launched this fiscal year, with the aim of further expanding production capacity in Japan, improving profitability and accelerating the globalization of the business.」
The Company has reaffirmed its policy of expanding production capacity, improving profitability and pursuing globalization based on the Mid-Term Business Strategy Vision. - FY2017RestatedAnnual report
「By steadily implementing these initiatives, we will seek to expand revenue while reducing costs, with the aim of building a resilient earnings structure capable of generating recurring and stable profits.」
The Company continues to target the establishment of a stable earnings structure through sales growth and cost reductions. - FY2016First statedAnnual report
「An urgent priority is to build a resilient earnings structure capable of generating recurring and stable profits through revenue growth, strengthening the production system and reducing costs.」
The Company identifies the development of a stable earnings structure, supported by revenue growth, a stronger production system and cost reductions, as a key priority.